Icon

SUTENT (nda021938)- (EQ 12.5MG BASE,EQ 25MG BASE,EQ 50MG BASE,EQ 37.5MG BASE)

SUNITINIB MALATE CPPI CV
EQ 12.5MG BASE,EQ 25MG BASE,EQ 50MG BASE,EQ 37.5MG BASE
Yes No
2021-Aug-15 2011-Jan-26
None None
None No
SUTENT is a kinase inhibitor indicated for: • treatment of adult patients with gastrointestinal stromal tumor (GIST) after disease progression on or intolerance to imatinib mesylate. • treatment of adult patients with advanced renal cell carcinoma (RCC). • adjuvant treatment of adult patients at high risk of recurrent RCC following nephrectomy. • treatment of progressive, well-differentiated pancreatic neuroendocrine tumors (pNET) in adult patients with unresectable locally advanced or metastatic disease.
7 0 6
Total Other Developers 15
Drugs with Suitability No
EQ 12.5MG BASE ** ** Up - -
EQ 25MG BASE ** ** Up - -
EQ 50MG BASE ** ** - - -
EQ 37.5MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 4
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** **** ** ***. *********** ** *** ****** **** ********** ****, *** **, ******, ****** **** (**) *****, ****** ****** (***) ***
****** *** ***** *** ************** ********** ******* *********** ****** **. ****, *****, ***** ********* ** ***** *** ***** ****** *** ***** *** *** ******, ***** (***) ***
****** ** ****** **.*****'* ************ ******* *********** ** ** ** & ** ** **, ***** - ***, ****, *******,, *************, ****** ******* *** ***, ***** (***) ***
****** ******* ***** **** ******* ******* *********** **** **. *-*/*, ****** ********** ****** ****** ********, *********** ********, ***** **** ******, ***** (***) ***
****** ***** ****** ******** ************* (*****) ******* *** *********** **** *** *** ********** ******, *** ***, **********, *** ****, ***** (***) ***
****** ***** ****** ***** ****** ************ ******* *********** ****-*, **. **. ***, *** & ***, ******* *******, ********* ******, *******-**********, ********* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.